Inactive Instrument
Company American Renal Associates Holdings, Inc.
Stocks
ARA
US0292271055
Healthcare Facilities & Services
Business description: American Renal Associates Holdings, Inc.

Sales by Activity: American Renal Associates Holdings, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
The Ownership and Operation of Dialysis Clinics | 823M |
Geographical breakdown of sales: American Renal Associates Holdings, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
United States | 823M |
Executive Committee: American Renal Associates Holdings, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
David Doerr
CEO | Chief Executive Officer | 56 | 31/01/2025 |
Syed Kamal
PSD | President | 73 | 31/12/1998 |
George Attmore
DFI | Director of Finance/CFO | - | - |
Geoffrey Walker
CTO | Chief Tech/Sci/R&D Officer | - | - |
Steve Duke
CTO | Chief Tech/Sci/R&D Officer | - | - |
Company details: American Renal Associates Holdings, Inc.
American Renal Associates Holdings, Inc.
500 Cummings Center
01915, Beverly
+978 922 3080
http://www.innovativerenal.com
Other Healthcare Facilities & Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.17% | +0.11% | +31.99% | +41.54% | 120B | ||
| +0.01% | +5.99% | +5.99% | +57.47% | 92.93B | ||
| +0.03% | -1.49% | -3.46% | +57.13% | 30.26B | ||
| -0.21% | +3.55% | +35.31% | +83.06% | 26.92B | ||
| -0.78% | +5.30% | +55.20% | +277.14% | 22.43B | ||
| +1.43% | +2.16% | -1.39% | -5.26% | 22.19B | ||
| +0.79% | +4.32% | -8.60% | +16.39% | 14.64B | ||
| +0.29% | -0.86% | -7.49% | -8.91% | 12.46B | ||
| +1.54% | -0.11% | +25.75% | +74.67% | 11.26B | ||
| Average | +0.47% | +2.17% | +14.81% | +65.91% | 39.27B | |
| Weighted average by Cap. | +0.52% | +2.42% | +18.48% | +60.47% |

















